Introduction: We assessed the possible consequences of applying the National Institute of Health and Clinical Excellence (NICE) guidelines for imaging studies of children younger than 3 years with urinary tract infection (UTI) to clinical practice, in terms of altered diagnoses and treatment.
Material And Methods: In a retrospective cohort of 672 patients with UTI, we evaluated indications for and results of renal and bladder ultrasonography, voiding cystourethrography (VCUG), dimercaptosuccinic acid scintigraphy, UTI recurrence, antimicrobial prophylaxis (AMP), antireflux procedures, and other urological procedures.
Results: There were a total 125 patients with vesicoureteral reflux (VUR), of whom 59 patients (47%) would have been missed, had the NICE guidelines being applied. These included 20 of the 64 patients (31%) with dilating VUR and 13 of the 30 patients (43%) who underwent antireflux procedures. A VCUG would have been avoided in 184 patients (74%) with no VUR in VCUG.
Conclusion: Based on the results in this cohort of 672 patients, we cannot recommend the use of the NICE guidelines for imaging studies in children younger than 3 years with UTI.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/s-0034-1384646 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Melanoma: Assessment and Management summary of 2022 update of the NICE guidelines.
Br J Dermatol
January 2025
Research fellow and General surgery trainee, Royal Marsden Hospital, London, UK.
Melanoma is the fifth most common skin cancer in the UK, accounting for 4% of all new cancer cases, with a predicted 7% increase in incidence between 2014-35. In parallel, since the initial publication of the Melanoma NICE Guidelines in 2015, there has been a paradigm shift in the management of the disease, with the introduction of effective systemic therapies. These innovations have reshaped the management of melanoma throughout the patient journey, and improved clinical outcomes.
View Article and Find Full Text PDFImproving Adherence to National Institute for Health and Care Excellence (NICE) Guidelines for the Use of Tranexamic Acid in Primary Total Knee Arthroplasty: A Quality Improvement Initiative.
Cureus
December 2024
Orthopaedics, The Royal Wolverhampton National Health Service (NHS) Trust, Wolverhampton, GBR.
Background: Tranexamic acid (TXA) is a pharmacological agent used in reducing blood loss during orthopaedic surgeries, including total knee arthroplasty (TKA). Despite its proven efficacy and National Institute for Health and Care Excellence (NICE) guidelines recommending combined topical and intravenous administration, compliance in clinical practice often lags.
Objective: This study aimed to evaluate and improve adherence to NICE guidelines for TXA use during TKA through a quality improvement initiative.
A Scleroderma and Raynaud's UK (SRUK) national survey to explore rheumatologists' awareness, approaches to diagnosis and management and training needs within systemic sclerosis.
Rheumatol Adv Pract
December 2024
Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Objectives: Patients' outcomes and experiences can be affected by rheumatologist knowledge and awareness of systemic sclerosis (SSc). Our survey, directed at UK-based rheumatologists, aimed to expand our understanding of the above points along with their ability to keep up to date with guidelines defining best practice.
Methods: Rheumatologists were invited to participate in an online survey, with the results analysed and presented descriptively and graphically by SRUK.
Variation in the commissioning of specialist weight management services and bariatric surgery across England: Results of a freedom of information-based mapping exercise across the 42 integrated Care Systems of England.
Clin Obes
January 2025
Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Specialist weight management services including bariatric surgery are commissioned within regions of England called Integrated Care Systems (ICSs) with eligibility and treatment guidelines determined as part of the National Institute for Health and Care Excellence (NICE) guidance. Reported variation in commissioning and bariatric surgery eligibility criteria has not been previously mapped. Freedom of Information (FOI) requests provide a tool, supported by legislation, to ask questions of public authorities including ICSs such that they must respond accurately.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!